The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1010-1018

  Walsh, Patrick T ^a   O'Connor, Rosemary ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Apoptosis; Bcl xl; CD28; Fas; Insulin like growth factor I receptor

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD28 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 2; PROTEIN BCL X; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR AGGREGATION; RECEPTOR, IGF TYPE 1; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0033994661     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200004)30:4<1010::AID-IMMU1010>3.0.CO;2-C     Document Type: Article

References (44)

1. Linsley, P.S. and Ledbetter, J.A., The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993. 11: 191-212.
2. Sperling, A.I., Auger, J.A., Ehst, B.D., Rulifson, I.C., Thompson, C.B. and Bluestone, J.A., CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 1996. 157: 3909-3917.
3. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L. and Somoza, C., B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993. 366: 76-81.
4. Freeman, G.J., Freedman, A.S., Segil, J.M., Lee, G., Whitman, J.F. and Nadler, L.M., B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 1989. 143: 2714-2723.
5. Slavik, J.M., Hutchcroft, J.E. and Bierer, B., CD28/CTLA-4 and CD80/CD86 families, Immunol. Res. 1999. 19: 1-24.
6. Thompson, C.B., Lindsten, T., Ledbetter, J.A., Kinkel, S.L., Young, H.A., Emerson, S.G., Leiden, J.M. and June, C.H., CD28 activation pathway regulates the production of multiple T cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 1989. 86: 1333-1340.
7. Ward, S.G., CD28: a signaling perspective. Biochem. J. 1996 318: 361-380.
8. Boise, L.H., A.J. Minn, P.J. Noel, C.H. June, M.A. Accavitti, T. Lindsten, and Thompson, C.B., CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xl. Immunity 1996. 3: 87-98.
9. Yang, Y. and Wilson, J.M., CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996. 273: 1862-1864.
10. Dhein, J., Walczak, H., Baumier, C., Debatin, K. and Krammer, H.P., Autocrine T cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
11. Zheng, L., Trageser, C.L., Willerford, D.M. and Lenardo, M.J., T cell growth cytokines cause the super-induction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 1998. 160: 763-769.
12. Hildeman, D.A., Mitchell, T., Teague, K.T., Henson, P., Day, B.J., Kappler, J. and Marrack, P., Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999. 10: 735-744.
13. Boise, L.H., Minn, A.J., June, C.H., Lindsten, T. and Thompson, C.B., Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc. Natl. Acad. Sci. USA 1995. 92: 5491-5495.
14. Bourselian, T.E. and Bottomley, K., Survival of naïve CD4 T cells: roles of restricting versus selecting MHC class II and cytokine milieu. J. Immunol. 1999. 162: 3795-3801.
15. Akbar, A.N., Borthwick, N.J., Wickremasinghe, R.G., Panayoitidis, P., Pilling, D., Bofill, M., Krajeski, S., Reed, J.C. and Salmon, M., Intrerleukin-2 receptor common gamma chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic bcl-2, Bcl-xl) but not pro-apoptotic (bax, bcl-xs) gene expression. Eur. J. Immunol. 1996. 26: 294-299.
16. Marrack, P., Kappler, J. and Mitchell, T., Type I interferons keep activated T cells alive. J. Exp. Med. 1999. 189: 521-530.
17. O'Connor, R., Survival factors and apoptosis. Adv. Biochem. Eng./Biotechnol. 1998. 62: 138-165
18. Rodriguez-Tarduchy, G., Collins, M.K.L., Garcia, I. and Lopez-Rivas, A., Insulin-like growth factor-1 inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol. 1992. 149: 535-540.
19. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G.I., Baserga, R. and Blättler, W.A., Identification of domains of the IGF-IR that are required for protection from apoptosis. Mol. Cell Biol. 1997. 17: 427-435
20. Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C., Lutz, R.J., Evan, G.I. and Guild, B., Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995. 374: 733-736.
21. Johnson, E.W., Jones, L.A., and Kozak, R.W. Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. J. Immunol. 1992. 148: 63-71.
22. Clark, R., Strasser, J., McCabe, S.M., Robbins, K. and Jardieu, P., Insulin-like growth factor-I stimulation of lymphopoiesis. J. Clin. Invest. 1993. 92: 540-548.
23. Kozak, R.W., Haskell, J.F., Greenstein, L.A., Rechler, M.M., Waldman, T.A., and Nissley S.P., Type I and type II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes. Cell. Immunol. 1987. 109: 318-325.
24. Noel, P.J., Boise, L.H. and Thompson, C.B., Regulation of T cell activation by CD28 and CTLA-4. Adv. Exp. Med. Biol. 1996. 406: 209-217.
25. Resnicoff, M., Burgaud, J., Rotman, H.L., Abraham, D. and Baserga, R., Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res. 1995. 55: 3739-3741.
26. Rohlik, Q.T., Adams, D., Kull, F.C. Jr. and Jacobs, S., An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem. Biophys. Res. Commun. 1987. 149: 276-283.
27. Valentis, B. and Baserga, R., The IGF-IR protects tumor cells from apoptosis induced by high concentrations of serum. Biochem. Biophys. Res. Commun. 1996. 224: 362-369.
28. Neff, N.T., Prevette, D., Houenou, L.J., Lewis, M.E., Glicksman, M.A., Yin, Q.W. and Oppenheim, R.W., Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol. 1993. 24: 1578-1588.
29. Werner, H. and LeRoith, D., The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 1996. 168: 183-223.
30. Yin, D., Zhang, L., Wang, R., Radvanyi, L., Haudenschild, C., Fang, Q., Kehry, M.R. and Shi, Y., Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. J. Immunol. 1999. 163: 4328-4334.
31. Tschopp, J., Irmler, M. and Thome, M., Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 1998. 10: 552-558.
32. Djerbi, M., Srepanti, V., Catrina, A.I., Bogen, B., Biberfeld, P. and Grandien, A., The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 1999. 190: 125-132.
33. Hueber, A.O., Zornig, M., Lyon, D., Suda, T., Nagata, S. and Evan, G.I., Requirement for the CD95 receptor-ligand pathway in c-myc induced apoptosis. Science 1997. 278: 1305-1308.
34. Di Cristofano, A., Kotsi, P., Peng, Y.F., Cordon-Cardo, C., Elkon, K.B. and Pandolfi, P.P., Impaired Fas response in Pten+/-mice. Science 1999. 285: 2122-2125.
35. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G., Suppression of C-Myc-induced apoptosis by ras signaling through PI(3)K and PKB. Nature 1997. 385: 544-548.
36. Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Cooper, G.M., Segal, R., Kaplan, D.R. and Greenberg, M.E. Regulation of neuronal survival by the serine threonine kinase AKT. Science 1997. 275: 661-663.
37. Yang, E., Zha, J. Jockel, J., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J., Bad; a heterodimeric partner for Bcl-xl and Bcl-2 displaces bax and promotes cell death. Cell 1995. 80: 285-291.
38. Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S.J., Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-xl. Cell 1996. 87: 619-628.
39. Parry, R.V., Reif, K., Smith, G., Sansom, D., Hemmings, B.A. and Ward, S.G., Ligation of T cell costimulatory receptor CD28 activates the serine threonine protein kinase B. Eur. J. Immunol. 1997. 27: 2495-2501.
40. Musaro, A., McCullagh, K.J.A, Naya, F.J., Olson, E.N. and Rosenthal, N., IGF-I induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NFATc1. Nature 1999. 400: 581-585.
41. +-dependent calcineurin signalling pathway. Nature 1999. 400: 576-580.
42. Kaleko, M., Rutter, W.J. and Miller, A.D., Over-expression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell Biol. 1990. 10: 464-473.
43. Romano, G., Prisco, M., Zanocco-Marani, T., Peruzzi, F., Valentinis, B. and Baserga, R., Dissociation between resistance to apoptosis and the transformed phenotype in IGF-IR signaling. J Cell. Biochem. 1999. 72: 294-310.
44. Robertson, M.J., Manley, T.J., Pichert, G., Cameron, C., Cochran, K.J., Levine, H. and Ritz, J., Expressional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma 1995. 17: 51-61.